NANO-GBM trial of AGuIX nanoparticles with radiotherapy and temozolomide in the treatment of newly diagnosed Glioblastoma: Phase 1b outcomes and MRI-based biodistribution

Authors: J. Biau, X. Durando, F. Boux, I. Molnar, J. Moreau, B. Leyrat, F. Guillemin, A. Lavielle, Y. Cremillieux, K. Seddik, S. Dufort, O. De Beaumont, E. Thivat, G. Le Duc

Source: Clinical and Translational Radiation Oncology, Vol 48, Iss , Pp 100833- (2024)

Subject Terms: Glioblastoma, Radiotherapy, Nanoparticles, AGuIX, Medical physics. Medical radiology. Nuclear medicine, R895-920, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2405630824001101; https://doaj.org/toc/2405-6308

Access URL: https://doaj.org/article/2598e837e2d34210afbaeec03af820e2